Tan DSP - Search Results

1

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.

Hoppe MM, Jaynes P, Wardyn JD, Upadhyayula SS, Tan TZ, Lie S, Lim DGZ, Pang BNK, Lim S, P S Yeong J, Karnezis A, Chiu DS, Leung S, Huntsman DG, Sedukhina AS, Sato K, Topp MD, Scott CL, Choi H, Patel NR, Brown R, Kaye SB, Pitt JJ, Tan DSP, Jeyasekharan AD. Hoppe MM, et al. Among authors: tan dsp, tan tz. EMBO Mol Med. 2021 May 7;13(5):e13366. doi: 10.15252/emmm.202013366. Epub 2021 Mar 11. EMBO Mol Med. 2021. PMID: 33709473 Free PMC article.

2

Ovarian clear cell adenocarcinoma: a continuing enigma.

Tan DS, Kaye S. Tan DS, et al. J Clin Pathol. 2007 Apr;60(4):355-60. doi: 10.1136/jcp.2006.040030. Epub 2006 Oct 3. J Clin Pathol. 2007. PMID: 17018684 Free PMC article. Review.

3

Ovarian cancer: can we reverse drug resistance?

Tan DS, Ang JE, Kaye SB. Tan DS, et al. Adv Exp Med Biol. 2008;622:153-67. doi: 10.1007/978-0-387-68969-2_13. Adv Exp Med Biol. 2008. PMID: 18546626 Review. No abstract available.

4

Weekly paclitaxel in the treatment of recurrent ovarian cancer.

Baird RD, Tan DS, Kaye SB. Baird RD, et al. Nat Rev Clin Oncol. 2010 Oct;7(10):575-82. doi: 10.1038/nrclinonc.2010.120. Epub 2010 Aug 3. Nat Rev Clin Oncol. 2010. PMID: 20683437 Review.

5

Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer.

Tan DS, Yap TA, Hutka M, Roxburgh P, Ang J, Banerjee S, Grzybowska E, Gourley C, Gore ME, Kaye SB. Tan DS, et al. Eur J Cancer. 2013 Apr;49(6):1246-53. doi: 10.1016/j.ejca.2012.11.016. Epub 2012 Dec 19. Eur J Cancer. 2013. PMID: 23265709

6

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Kipps E, Tan DS, Kaye SB. Kipps E, et al. Nat Rev Cancer. 2013 Apr;13(4):273-82. doi: 10.1038/nrc3432. Epub 2013 Feb 21. Nat Rev Cancer. 2013. PMID: 23426401 Free PMC article.

7

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma.

Tan DS, Miller RE, Kaye SB. Tan DS, et al. Br J Cancer. 2013 Apr 30;108(8):1553-9. doi: 10.1038/bjc.2013.126. Epub 2013 Apr 4. Br J Cancer. 2013. PMID: 23558892 Free PMC article. Review.

8

Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.

Heong V, Syn NL, Lee XW, Sapari NS, Koh XQ, Adam Isa ZF, Sy Lim J, Lim D, Pang B, Thian YL, Ng LK, Wong AL, Soo RA, Yong WP, Chee CE, Lee SC, Goh BC, Soong R, Tan DSP. Heong V, et al. Among authors: tan dsp. Int J Cancer. 2018 May 1;142(9):1890-1900. doi: 10.1002/ijc.31091. Epub 2017 Oct 17. Int J Cancer. 2018. PMID: 28994108 Free article.

9

Biomarkers for Homologous Recombination Deficiency in Cancer.

Hoppe MM, Sundar R, Tan DSP, Jeyasekharan AD. Hoppe MM, et al. Among authors: tan dsp. J Natl Cancer Inst. 2018 Jul 1;110(7):704-713. doi: 10.1093/jnci/djy085. J Natl Cancer Inst. 2018. PMID: 29788099 Review.

10

Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique.

Heong V, Tay D, Goh SE, Wee B, Tan TZ, Soo R, Pang B, Lim D, Gopinathan A, Ow S, Chee CE, Goh BC, Lee SC, Yong WP, Wong A, Omar MFM, Soong R, Tan DS. Heong V, et al. Cancers (Basel). 2020 Jun 17;12(6):1599. doi: 10.3390/cancers12061599. Cancers (Basel). 2020. PMID: 32560395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page